NCT00530881View on ClinicalTrials.gov

Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

October 31, 2006

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

PHX1149

Trial Locations (1)

92121

Multiple Sites, San Diego

Sponsors

Lead Sponsor

Phenomix
All Listed Sponsors
lead

Phenomix

INDUSTRY